Table 2.
Characteristic | Mean (sd) | Percentage |
---|---|---|
Age (yr) | 47 (15) | |
Gender | ||
Female | 77 | |
Male | 23 | |
Height (m) | 1.72 (0.09) | |
Weight (kg) | 79 (19) | |
BMI | 28 (7) | |
Menopausal status | ||
Premenopausal | 46 | |
Postmenopausal | 31 | |
Not applicable | 23 | |
TSH (mIU/liter) | 105 (75) | |
FT4 (ng/dl) | 0.23 (0.09) | |
Serum creatinine (mg/dl) | ||
All ages | 1.22 (0.30) | |
<35 yr | 1.09 (0.17) | |
35–49 yr | 1.13 (0.23) | |
50–64 yr | 1.24 (0.29) | |
>64 yr | 1.67 (0.27) | |
GFR (ml/min · 1.73 m2) | ||
All ages | 64 (21) | |
<35 yr | 75 (19) | |
35–49 yr | 68 (19) | |
50–64 yr | 59 (19) | |
>64 yr | 39 (10) | |
Baseline serum TSH (mIU/liter) | ||
All ages | 2.0 (1.5) | |
<35 yr | 1.7 (1.3) | |
35–49 yr | 1.7 (1.1) | |
50–64 yr | 2.1 (1.2) | |
>64 yr | 3.1 (2.5) | |
Days off l-T4 | 39 (5) | |
Days off T3 | 13 (1) | |
Thyroglobulin (ng/ml) | 85 (444), median 0 | |
Presence of thyroglobulin antibodies | ||
No | 83 | |
Yes | 17 | |
Distant metastases | ||
No | 87 | |
Yes | 13 | |
Presence of thyroid remnant | ||
Yes | 86 | |
No | 14 | |
Type of differentiated thyroid cancer | ||
Papillary | 74 | |
Follicular | 16 | |
Other variant | 10 | |
Years elapsed since thyroidectomy | 0.5 (1.2) | |
Years elapsed since last radioiodine therapy | 0.3 (0.7) | |
Initial radioiodine therapy | 79 | |
Subsequent radioiodine therapy or diagnostic scanning | 21 |